October 25, 2017 | Simon Jenkins
Sally Peyman studied Chemistry with Forensic Science and Toxicology at Hull, before moving on to a PhD focussed on the design and application of microfluidic devices for biomedical applications. She moved briefly to Imperial College to carry out postdoctoral work on nanosensors before moving to Leeds to work on microfluidics for the fabrication of microbubbles as a novel cancer treatment.
She has recently been made a University Academic Fellow and has started her own research group. Over the last 11 years she has researched microfluidics for rapid clinical diagnostics, for the fabrication of novel therapeutics and for single cell analysis to understand disease.
Sally is now investigating organ-on-chip microfluidics for modelling disease states and the rapid screening of new therapeutics.